🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Benjamin Solomon

The University of Melbourne

ORCID: 0000-0003-3059-5730

Also affiliated with Peter MacCallum Cancer Centre

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.452Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Papers

Driven by 9 papers — median percentile 58. Top paper: “First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC”.

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

New England Journal of Medicine(2023)10.1056/nejmoa2309457
N/A
4.6DataRank · unranked
218 citations

Benjamin Solomon, Herbert H. Loong, Keunchil Park, M. Pérol, Edurne Arriola +19 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2
N/A
3.5DataRank · unranked
168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial

Investigational New Drugs(2024)10.1007/s10637-023-01410-2
N/A
1.3DataRank · unranked
67 citations

Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H. Miller, Aaron R. Hansen +12 more

Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Science Translational Medicine(2010)10.1126/scitranslmed.3001451
N/A
1.0DataRank · unranked
823 citations

Martin L. Sos, Danila Seidel, Charles M. Perou, Thomas Zander, Johannes M. Heuckmann +66 more

Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration

Nature Medicine(2020)10.1038/s41591-019-0716-8
N/A
0.898DataRank · unranked
397 citations

Jeffrey W. Clark, Jared Weiss, Sai‐Hong Ignatius Ou, D. Ross Camidge, Benjamin Solomon +16 more

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology(2021)10.1038/s41571-021-00487-z
N/A
0.742DataRank · unranked
140 citations

Justin F. Gainor, Aparna Hegde, Alison M. Schram, Giuseppe Curigliano, Sumanta K. Pal +19 more

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC

Lung Cancer(2025)10.1016/j.lungcan.2025.108635
N/A
0.345DataRank · unranked
9 citations

Georgia Dimopoulou, Paul van Schil, David König, Laetitia Mauti, Malinda Itchins +17 more

A tailored approach to horizon scanning for cancer medicines

Journal of Cancer Policy(2023)10.1016/j.jcpo.2023.100441
N/A
0.241DataRank · unranked
4 citations

Yat Hang To, Marliese Alexander, Karen Trapani, Paolo A. Ascierto, Sophy Athan +28 more